RxDoctor Payments DataLook up a doctor →

Jessica Bennett, PA

Medical · Greeneville, TNNPI 1710239215

Payments from drug & device makers

$7,942in general payments, 2019–2025

Across 568 payments — averaging $13.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Novo Nordisk$1K
  • Pfizer$609
  • Otsuka America Pharmaceutical, Inc.$600
  • GSK$501
  • Lilly USA, LLC$421
  • plus $3K from 32 others

What the payments were for

  • Food & beverage$7,85799%
  • Education$851%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$7,942 in reported general payments places this provider in the 90th percentile of 480 medical providers in Tennessee.

See all medical providers in Tennessee

Medicare billing

Part B allowed, 2024
$28,857
Medicare patients
89
Services billed
500

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide177$186,004
JardianceEmpagliflozin144$126,444
Trelegy ElliptaFluticasone/Umeclidin/Vilanter93$90,802
RexultiBrexpiprazole54$79,060
EliquisApixaban110$76,814
OtezlaApremilast14$75,819
MounjaroTirzepatide60$70,612
XareltoRivaroxaban62$56,651
TrulicityDulaglutide45$49,207
LinzessLinaclotide40$31,513
FarxigaDapagliflozin Propanediol34$26,979
Repatha SureclickEvolocumab29$26,704
CaplytaLumateperone Tosylate13$23,936
RybelsusSemaglutide25$23,706
Nurtec OdtRimegepant Sulfate12$23,338

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$1,025$209,710202 claims
Boehringer IngelheimJardiance, Spiriva Respimat, Tradjenta, Stiolto Respimat$379$174,663205 claims
Lilly USA, LLCMounjaro, Trulicity$421$119,819105 claims
PfizerEliquis, Nurtec Odt$609$100,152122 claims
GSKTrelegy Ellipta$501$90,80293 claims
Otsuka America Pharmaceutical, Inc.Rexulti$600$79,06054 claims
AmgenOtezla$386$75,81914 claims
Johnson & JohnsonXarelto$45$56,65162 claims
AbbVieLinzess, Vraylar$1,340$52,00554 claims
AstraZenecaFarxiga, Symbicort$146$33,23351 claims
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta$80$23,93613 claims
Sumitomo Pharma America, Inc.Gemtesa$91$19,38422 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 480 medical providers in Tennessee.

Other medical in Greeneville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →